A share price of Zimmer Biomet Holdings Inc [ZBH] is currently trading at $110.65, up 2.46%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ZBH shares have gain 5.00% over the last week, with a monthly amount glided 7.75%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Zimmer Biomet Holdings Inc [NYSE: ZBH] stock has seen the most recent analyst activity on December 17, 2024, when JP Morgan upgraded its rating to a Overweight and also boosted its price target to $128 from $125. On July 01, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $115 on the stock. Goldman started tracking the stock assigning a Neutral rating and suggested a price target of $129 on May 30, 2024. Argus upgraded its rating to a Buy but $150 remained the price target by the analyst firm on May 21, 2024. Evercore ISI downgraded its rating to In-line for this stock on January 04, 2024, and downed its price target to $125. In a note dated October 20, 2023, ROTH MKM initiated an Neutral rating and provided a target price of $120 on this stock.
Zimmer Biomet Holdings Inc experienced fluctuations in its stock price throughout the past year between $97.69 and $133.90. Currently, Wall Street analysts expect the stock to reach $122 within the next 12 months. Zimmer Biomet Holdings Inc [NYSE: ZBH] shares were valued at $110.65 at the most recent close of the market. An investor can expect a potential return of 10.26% based on the average ZBH price forecast.
Analyzing the ZBH fundamentals
Trailing Twelve Months sales for Zimmer Biomet Holdings Inc [NYSE:ZBH] were 7.68B which represents 4.28% growth. Gross Profit Margin for this corporation currently stands at 0.66% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.12%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.07 and Total Capital is 0.07. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.43.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 108.05 points at the first support level, and at 105.44 for the second support level. However, for the 1st resistance point, the stock is sitting at 112.60, and for the 2nd resistance point, it is at 114.55.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Zimmer Biomet Holdings Inc [NYSE:ZBH] is 1.91. In addition, the Quick Ratio stands at 0.99 and the Cash Ratio stands at 0.33. Considering the valuation of this stock, the price to sales ratio is 2.87, the price to book ratio is 1.77 and price to earnings (TTM) ratio is 24.94.
Transactions by insiders
Recent insider trading involved Winkler Lori, SVP and CHRO, that happened on Mar 05 ’25 when 1443.0 shares were sold. Officer, Winkler Lori completed a deal on Mar 05 ’25 to buy 1443.0 shares. Meanwhile, Group President, Asia Pacific Yi Sang sold 12857.0 shares on May 31 ’24.
